NCT02482883View on ClinicalTrials.gov

Evaluation of Transcutaneous Trigeminal Nerve Stimulation for Prevention of Cerebral Vasospasm After Subarachnoid Haemorrhage

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

February 28, 2019

Study Completion Date

May 31, 2019

Conditions
Subarachnoid Haemorrhage (SAH)
Interventions
DEVICE

Transcutaneous Electrical Nerve Stimulation (TENS)

All patients will undergo placement of a facial transcutaneous electrical nervous stimulation (TENS) device, but device activation will be randomized \[active stimulation vs non-active (placebo) stimulation\], for an initial period of 10 days.

Trial Locations (1)

86021

BATAILLE, Poitiers

All Listed Sponsors
lead

Poitiers University Hospital

OTHER

NCT02482883 - Evaluation of Transcutaneous Trigeminal Nerve Stimulation for Prevention of Cerebral Vasospasm After Subarachnoid Haemorrhage | Biotech Hunter | Biotech Hunter